Skip to main content
. 2020 Sep 11;4:129. Originally published 2019 Sep 4. [Version 2] doi: 10.12688/wellcomeopenres.15408.2

Figure 3. The possible co-payments required by patients for the drug costs relating to interferon-based treatment.

Figure 3.

The values summarize the different potential patient co-payment rates for the drug costs relating to interferon-based treatment (based on Figure 2 and Equation 2). Note, these only pertain to the drugs and not the other resources/services.